We look forward to sharing our newest updates to our spatial epigenome assays at #FOGBoston 🚀

We are excited to share the latest version of DBiT-seq, Flowgel 210! This new design offers unparalleled resolution and throughput into spatial epigenomics 🚀 #Epigenetics #Genomics Check out our website for more bit.ly/4aJ0wtN

Our brilliant scientist, Katelyn, is currently in attendance at #multiomics in Precision Medicine 2024 at UPenn, showcasing our latest research and advancements! We're thrilled to share our progress with the scientific community 🧬 #epigenetics

Officially out! Our latest story exploiting NAD metabolism defects in CNS tumors! Another creative/disruptive collab, this time w/ the Saltzman Lab testing CED w/ nanoparticle NAMPTi’s! aacrjournals.org/mct/article/do… Yale Radiation Oncology Residency Yale Cancer Center Yale BME City of Hope Charles Brenner, PhD

Epigenetics is changing our understanding of diseases. AtlasXomics creates spatial multiomics maps of tissue – generating over 1000 TB of data and serving 70+ labs on LatchBio – to help scientists uncover the epigenetic drivers of disease. They are pioneering a nascent field

New in Models and Technologies from the August Issue—Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. bit.ly/3YMSE8c Matthew Murray, Ph.D. Saltzman Lab Ranjit Bindra,MD/PhD #openaccess

Congratulations to my other lab bestie Katelyn Noronha! So excited this is out!!

We are at #SITC2024! Check out the latest in spatial epigenomics analysis at poster 1361

Cheers to a year of breakthroughs at Atlasxomics—and an even more innovative 2025 ahead! Together, let’s push the boundaries of discovery. #epigenetics #genomics

Check out our White paper! While standard assays obscure crucial spatial and cellular differences, high-resolution methods like our spatial ATAC-seq illuminate the epigenetic underpinnings of cancer progression and therapy resistance. Learn more in our recent stomach cancer case

Unlock the hidden secrets of tissues with AtlasXomics! Discover how our revolutionary DBiT-seq enables spatial epigenomics. #Epigenetics #Genomics #SpatialBiology

Our CEO, Ken Wang, takes the stage at Nvidia’s GTC conference, sharing how our advanced computational pipelines are shaping the future of spatial epigenomics. Stay tuned for more innovative breakthroughs! #GTC #nvidia #epigenetics

Want to run spatial epigenomics in your lab? Our DBiT-seq kit makes it easy. Watch how it works! #epigenetics #spatialbiology

So great to see our lab’s work on NAPRT as a biomarker continuing on in RMS!

🧬 Kudos to The Deng Lab Penn Medicine! New Nat Comms: spatial FFPE-ATAC for DBiT-seq maps chromatin in archived brain, thymus & melanoma (10 µm) with AtlasXomics FlowGel featured. We’re working to bring this to researchers. Reach out to learn more! #SpatialOmics #Epigenetics

Absolutely thrilled to have helped the incredible team at YCGA get up and running with our platform! Excited to see what they'll uncover with spatial epigenomics.

🚨 New preprint! Dr. Marco Gallo’s lab used AtlasXomics Spatial ATAC‑seq to map chromatin in GBM and found nested epigenomic niches that drive cell‑state plasticity. Dive in: biorxiv.org/content/10.110… #Glioblastoma #CancerResearch #Epigenetics

Spatial FFPE ATAC-seq has arrived! AtlasXomics now brings single-cell chromatin accessibility mapping to FFPE tissue, unlocking spatial epigenomic insights from the world’s vast archives of clinical samples. Using our 5.5 × 5.5 mm chip at 10 µm resolution, we can now profile